<p><strong><span class="legendSpanClass"><span class="xn-location">SAN FRANCISCO</span></span></strong> &#8212; Venture Capital (VC) investment in healthcare grew to <span class="xn-money">$23 billion</span> in 2024, from <span class="xn-money">$20 billion</span> in 2023, as artificial intelligence (AI) clearly established product fit in the healthcare sector, according to the latest market insights report from <b><u><a href="https://c212.net/c/link/?t=0&;l=en&;o=4336073-1&;h=1323596834&;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4187822-1%26h%3D3899473679%26u%3Dhttps%253A%252F%252Fwww.svb.com%252Fabout-us%252Fsvb-client-faqs%252F%253Futm_source%253Dgoogle%2526utm_medium%253Dcpc%2526utm_campaign%253Dus-2023-08-lg-br-na-na-na-na%2526utm_content%253Dquestions-svb-is-svb-open%2526utm_term%253Dis%252520svb%252520back%2526gad_source%253D1%2526gclid%253DCj0KCQjw6PGxBhCVARIsAIumnWZX0CnEn4nSO76h3BeV2fAwMGmEtES1VzeVSSyZAsX9KAtn4XvWTKEaAglREALw_wcB%26a%3DSilicon%2BValley%2BBank&;a=Silicon+Valley+Bank" target="_blank" rel="nofollow noopener">Silicon Valley Bank</a></u></b> (SVB), a division of First Citizens Bank. AI continues to take center stage, especially across biopharma, with 30% of healthcare investment in 2024 going to companies leveraging AI.</p>
<p>With more than <span class="xn-money">$5 billion</span> in 2024, investment in biopharma AI was the story of the year. The sector saw a 300% increase in investment since 2023, surging past 2021 total capital invested by nearly <span class="xn-money">$2 billion</span>. Investment was largely driven by mega deals, with deals over <span class="xn-money">$100 million</span> accounting for 71% of total 2024 investment in biopharma AI, according to the report.</p>
<p>&#8220;In 2025, we could see a steady yet modest increase in both the volume and value of investments across various healthcare sectors,&#8221; said <span class="xn-person">Jackie Spencer</span>, Head of Relationship Management for Life Science and Healthcare Banking at Silicon Valley Bank and author of the annual <b><a href="https://c212.net/c/link/?t=0&;l=en&;o=4336073-1&;h=3749804501&;u=https%3A%2F%2Fwww.svb.com%2Ftrends-insights%2Freports%2Fhealthcare-investments-and-exits%2F&;a=Healthcare+Investments+and+Exits+Report" target="_blank" rel="nofollow noopener">Healthcare Investments and Exits Report</a></b>. &#8220;However, despite this growth, IPO activity is likely to remain subdued as market conditions continue to stabilize and investors remain cautious. Advancements in AI are poised to revolutionize drug development and clinical trial management, driving efficiencies, precision, and speed in bringing new therapies to market.&#8221;</p>
<p>SVB&#8217;s 2025 Healthcare Investment and Exits report analyzes and predicts trends for venture capital investing, fundraising, and exits across healthtech, biopharma, diagnostics/tools (dx/tools), and device sectors in the US.</p>
<p>Key report findings:</p>
<ul >
<li><b>Seed Rounds</b>: Seed rounds rose to 40% of all deals as investors look forward. Among all companies receiving a seed deal in 2024, 35% are leveraging AI – up from 25% in 2023.</li>
<li><b>Biopharma</b>: With AI-driven protein design gaining momentum and results from clinical trials for AI-designed drugs on the way, excitement for biopharma AI is expected to remain high.</li>
<li><b>Valuations</b>: Valuations saw a 1.5x median increase among companies raising after a down round.</li>
<li><b>Healthtech</b>: With notable raises going to companies with proven track records and strong histories, a new crop of healthtech startups must prove themselves quickly.</li>
<li><b>Dx/Tools</b>: Investments are slowly rising. Liquid biopsies and precision diagnostics companies are showing strength, combining their close relationship to the success of precision therapy with a relatively untapped potential to collect and aggregate data.</li>
<li><b>Device</b>: Hospitals might turn out to be the key to reviving a slow device startup space, with new IPOs largely focused on the acute care space. Advances in imaging and monitoring tech are restoring interest that&#8217;s been lost from wearables and home care.</li>
</ul>

SAN FRANCISCO -- Wispr, the voice-to-text AI that turns speech into clear, polished writing in every…
SAN FRANCISCO -- Numeric, an AI accounting automation platform, has raised a $51 million Series…
Apple has announced 45 finalists for this year’s App Store Awards, recognizing the best apps…
The University of California (UC) and the California Nurses Association (CNA) have reached a tentative…
SAN FRANCISCO -- House Rx, a health tech company focused on making specialty medications more accessible and…
Britain's King has given an award to the King of NVIDIA! NVIDIA founder and CEO…